Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : NNBM - SI Branch -- Ignore unavailable to you. Want to Upgrade?

To: abuelita who wrote (45016)	7/12/2005 1:50:42 AM
From: Wharf Rat	Respond to of 104160

touche' :>)

To: abuelita who wrote (45016)	7/12/2005 8:09:55 AM
From: stockman_scott	Read Replies (1) \| Respond to of 104160

Curry Spice Shuts Down Melanoma By Kathleen Doheny HealthDay Reporter July 11 (HealthDay News) -- Curcumin, the ingredient that gives curry its yellow hue, blocked the growth of melanoma tumor cells and even stimulated their death in the laboratory, researchers report. "We could completely inhibit the growth of the tumor if we used a big enough dose," said study co-author Bharat B. Aggarwal, chief of the Cytokine Research Section in the Department of Experimental Therapeutics at the University of Texas M.D. Anderson Cancer Center in Houston. His report is set to appear in the Aug. 15 issue of Cancer. Aggarwal and his colleagues exposed three different cell lines of melanoma to curcumin, which is found in turmeric, a spice used in curry dishes. Exposure to curcumin decreased the cell viability of all three cell lines, they found. They zeroed in on a molecule called NF-kappa B, which is known to be overactive in several types of tumors, including melanoma. The turmeric shut down the molecule and that lead to inhibition of the tumor growth, Aggarwal explained. In other preliminary research, including some by Aggarwal's team, turmeric has proven useful in treating multiple myeloma, as well as breast and pancreatic cancers. The new findings were praised by Costas Koumenis, an associate professor of radiation oncology at Wake Forest University School of Medicine. "I think it's an interesting and provocative study," he said. "It shows some new insight into how turmeric is working to inhibit the growth of melanoma cells." Koumenis is studying whether curcumin can be used to enhance radiation therapy in deadly brain tumors called gliomas and other tumors in animals. The Texas researchers also pinpointed exactly how the spice ingredient works to kill tumor cells, he said. "It gives us a better understanding of the mechanism of how it works to inhibit melanoma growth." But he cautioned that the study was done in the lab, and the spice must be tested on animals, and eventually people, before it is proven to be effective. For the past 20 years, Koumenis said, turmeric has been studied, mostly as an agent to prevent cancer. For instance, some researchers have found an association between diets rich in curcumin and reduced rates of colon cancer. But more recently, the focus has shifted to study the spice as a cancer treatment. forbes.com